首页 | 本学科首页   官方微博 | 高级检索  
     

靶向黏蛋白1嵌合抗原受体修饰的Jurkat T细胞特异杀伤肝癌细胞
引用本文:马宜冬,王真,巩睿智,李林芳,吴红平,金华君,钱其军. 靶向黏蛋白1嵌合抗原受体修饰的Jurkat T细胞特异杀伤肝癌细胞[J]. 第二军医大学学报, 2014, 35(11): 1177-1182
作者姓名:马宜冬  王真  巩睿智  李林芳  吴红平  金华君  钱其军
作者单位:苏州大学医学部基础医学与生物科学学院细胞生物学系,第二军医大学附属东方肝胆外科医院研究生队肿瘤学专业 上海,第二军医大学附属东方肝胆外科医院研究生队肿瘤学专业 上海,第二军医大学东方肝胆外科医院基因-病毒治疗实验室,第二军医大学东方肝胆外科医院基因-病毒治疗实验室,第二军医大学东方肝胆外科医院基因-病毒治疗实验室,第二军医大学东方肝胆外科医院基因-病毒治疗实验室
基金项目:1.艾滋病和病毒肝炎等重大传染病的防治重大专项,“肝癌过继细胞治疗新技术与新方案的研究”,编号2013ZX10002-010-007;2.上海工程技术研究中心专项课题,“上海细胞治疗工程技术研究中心”,编号12DZ2251600. Supported by:1.The major infectious diseases such as AIDS and virus hepatitis prevention and treatment projects, No. 2013 zx10002-010-007; 2. The important project ofS Shanghai engineering technology research center,
摘    要:目的探讨靶向黏蛋白1(mucin 1,MUC1)的嵌合抗原受体(chimeric antigen receptor,CAR)修饰的T细胞株(CAR-T)对MUC1高表达肝癌细胞的特异杀伤能力。方法分别构建第1代与第3代靶向MUC1的CAR基因表达框(MUC1-CAR与G3MUC1-CAR),并将其装入慢病毒载体,利用获得的重组慢病毒感染Jurkat细胞,通过CCK-8法、ELISA法、乳酸脱氢酶释放实验,分别检测在MUC1抗原存在条件下,CAR-T细胞的增殖、IL-2分泌量、杀伤作用。结果成功构建2种靶向MUC1嵌合抗原受体表达框的重组慢病毒Jurkat CAR-T细胞株。两种Jurkat CAR-T细胞均能特异识别MUC1分子,杀伤MUC1高表达的肝癌细胞QGY-7701,而对MUC1低表达的正常肝细胞基本不杀伤;第3代CAR修饰的Jurkat T细胞接触MUC1分子后,其增殖速度、IL-2分泌量和杀伤效率均优于第1代MUC1修饰细胞(P<0.05或P<0.01)。结论靶向MUC1的Jurkat CAR-T细胞能特异杀伤MUC1高表达的肝癌细胞。

关 键 词:嵌合抗原受体  黏蛋白1  Jurkat细胞  肝细胞癌
收稿时间:2014-04-12
修稿时间:2014-08-08

Specific cytotoxicity of MUC1 chimeric antigen receptor-engineered Jurkat T cells against hepatocellular carcinoma
MA Yi-dong,WANG Zhen,GONG Rui-zhi,LI Lin-fang,WU Hong-ping,JIN Hua-jun and QIAN Qi-jun. Specific cytotoxicity of MUC1 chimeric antigen receptor-engineered Jurkat T cells against hepatocellular carcinoma[J]. Former Academic Journal of Second Military Medical University, 2014, 35(11): 1177-1182
Authors:MA Yi-dong  WANG Zhen  GONG Rui-zhi  LI Lin-fang  WU Hong-ping  JIN Hua-jun  QIAN Qi-jun
Affiliation:Laboratory of Viral and Gene Therapy,Eastern Hepatobiliary Surgery Hospital
Abstract:Objective To investigate the killing effect of MUC1-specific chimeric antigen receptor (CAR)-engineered Jurkat T cells on hepatocellular carcinoma (HCC) cells. Methods The expression cassettes of both the first and the third generation MUC1-specific CAR gene (i.e. MUC1-CAR and G3MUC1-CAR) were constructed and cloned into lentivirus transfer plasmids, respectively. Then, the obtained recombinant lentiviruses carrying the MUC1-specific CAR gene and hrGFP reporter genes were used to infect Jurkat T cells in vitro to establish MUC1-sepcific CAR-engineered Jurkat cells (i.e. CAR-T cells). Subsequently, the assays of CCK-8, ELISA, and LDH were used to detect the cell proliferation, IL-2 secretion and killing effect of the CAR-T cells, respectively. Results We successfully constructed the expression cassettes of MUC1-sepcific CAR gene and the corresponding recombinant lentivirus, established the MUC1-specific CAR-engineered Jurkat T cells. Both MUC1-specific CARs-engineered Jurkat T cells could recognize MUC1 molecule and specifically kill MUC1 over-expression HCC cells while leave normal hepatic cells almost undamaged. In addition, the cell proliferation, the secretion of IL-2 and killing effect of the G3MUC1-CAR-engineered Jurkat T cells was significantly superior to the MUC1-CAR-engineered counterpart. Conclusion The MUC1-sepcific CAR-engineered Jurkat T cells can specifically kill MUC1 over-expression HCC cell.
Keywords:chimeric antigen receptor   MUC1   Jurkat T cell   hepatocellular carcinoma
本文献已被 CNKI 等数据库收录!
点击此处可从《第二军医大学学报》浏览原始摘要信息
点击此处可从《第二军医大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号